nach oben

Cardiovascular Toxicology

Erschienen in:

05.01.2021

Validation of Corrected and Dispersed QT as Predictors of Adverse Outcomes in Acute Cardiotoxicities

verfasst von: Ghada N. El-Sarnagawy, Aliaa E. Shaban, Heba I. Lashin

Erschienen in: Cardiovascular Toxicology | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Acute cardiovascular poisoning is a major cause of adverse outcomes in poisoning emergencies. The prognostic validity of corrected QT (QTc) and dispersed QT (QTd) in these outcomes is still limited. The present study aimed to determine the risk factors of mortality, adverse cardiovascular events (ACVE), and intensive care unit (ICU) admission in patients with acute cardiovascular toxicities and assess the validity of QTc and QTd intervals in predicting these outcomes. This study was conducted on adult patients admitted to Tanta University Poison Control Center with a history of acute cardiotoxic drugs or toxins exposure. The demographic and toxicological data of patients were recorded. Clinical examination, routine laboratory investigations, ECG grading, and measurement of QTc and QTd were performed. The patients were grouped according to their adverse outcomes. Among the included patients, 51 (31.48%) patients died, 61 (37.65%) patients had ACVE, and 68 (41.98%) patients required ICU admission. The most common cause of poisoning is aluminum phosphide, followed by cholinesterase inhibitors. QTd and QTdc showed no significant difference among outcome groups. The best cut-off values of QTc to predict mortality, ACVE, and ICU admission were > 491.1 ms, > 497.9 ms, and ≥ 491.9 ms, respectively. The derived cut-off QTc values were independent predictors for all adverse outcomes after adjusting for poison type, serum HCO3, and pulse. The highest odds ratios for all adverse outcomes were observed in aluminum phosphide poisoning and low HCO3 < 18 mmol/L. Thus, serum HCO3 and QTc interval should be monitored for acute cardiotoxicities, especially in aluminum phosphide and cholinesterase inhibitors poisoning.

Chandravanshi, L. P. (2018). Assessment and diagnosis of poisoning with characteristics features in living or dead. Journal of Forensic Sciences & Criminal Investigation. https://doi.org/10.19080/jfsci.2018.10.555796.CrossRef

Malangu, N., & Ogunbanjo, G. A. (2009). A profile of acute poisoning at selected hospitals in South Africa. Southern African Journal of Epidemiology and Infection. https://doi.org/10.1080/10158782.2009.11441343.CrossRef

Saglam, Z. A., Demir, B., Ataoglu, E. H., Yenigun, M., Temiz, L. U., & Saler, T. (2012). Causes of acute poisoning in adults: A retrospective study, in a hospital in Istanbul, Turkey. Journal of Public Health (Germany). https://doi.org/10.1007/s10389-011-0436-0.CrossRef

Mehrpour, O., Akbari, A., Jahani, F., Amirabadizadeh, A., Allahyari, E., Mansouri, B., & Ng, P. C. (2018). Epidemiological and clinical profiles of acute poisoning in patients admitted to the intensive care unit in eastern Iran (2010 to 2017). BMC Emergency Medicine. https://doi.org/10.1186/s12873-018-0181-6.CrossRefPubMedPubMedCentral

Ramesha, K. N., Rao, K. B. H., & Kumar, G. S. (2009). Pattern and outcome of acute poisoning cases in a tertiary care hospital in Karnataka, India. Indian Journal of Critical Care Medicine, 13(3), 152–155.CrossRef

Riedmaier, S., & Zanger, U. M. (2012). Cardiovascular drugs. Metabolism of Drugs and Other Xenobiotics. https://doi.org/10.1002/9783527630905.ch12.CrossRef

Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remiao, F., Pourová, J., et al. (2018). Comprehensive review of cardiovascular toxicity of drugs and related agents. Medicinal Research Reviews. https://doi.org/10.1002/med.21476.CrossRefPubMedPubMedCentral

Carreiro, S., Miller, S., Wang, B., Wax, P., Campleman, S., & Manini, A. F. (2020). Clinical predictors of adverse cardiovascular events for acute pediatric drug exposures. Clinical Toxicology. https://doi.org/10.1080/15563650.2019.1634272.CrossRefPubMed

Bronstein, A. C., Spyker, D. A., Cantilena, L. R., Green, J. L., Rumack, B. H., & Giffin, S. L. (2010). 2009 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 27th annual report. Clinical Toxicology. https://doi.org/10.3109/15563650.2010.543906.CrossRefPubMed

10.

Manini, A. F., Hoffman, R. S., Stimmel, B., & Vlahov, D. (2015). Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Academic Emergency Medicine. https://doi.org/10.1111/acem.12658.CrossRefPubMedPubMedCentral

11.

Manini, A. F., Nelson, L. S., Stimmel, B., Vlahov, D., & Hoffman, R. S. (2012). Incidence of adverse cardiovascular events in adults following drug overdose. Academic Emergency Medicine. https://doi.org/10.1111/j.1553-2712.2012.01397.x.CrossRefPubMedPubMedCentral

12.

Isiguzo, G. C., Iroezindu, M. O., Muoneme, A. S., & Okeahialam, B. N. (2017). Knowledge and utilization of electrocardiogram among resident doctors in family medicine in Nigeria. Nigerian Journal of Clinical Practice, 20(9), 1133–1138.CrossRef

13.

Holstege, C. P., Eldridge, D. L., & Rowden, A. K. (2006). ECG manifestations: The poisoned patient. Emergency Medicine Clinics of North America, 24(1), 159–177.CrossRef

14.

Hansen, C. S., Pottegård, A., Ekelund, U., Kildegaard Jensen, H., Lundager Forberg, J., et al. (2018). Association between QTc prolongation and mortality in patients with suspected poisoning in the emergency department: A transnational propensity score matched cohort study. British Medical Journal Open, 8, e020036.

15.

Mahmud, R., Gray, A., Nabeebaccus, A., & Whyte, M. B. (2018). Incidence and outcomes of long QTc in acute medical admissions. International Journal of Clinical Practice. https://doi.org/10.1111/ijcp.13250.CrossRefPubMedPubMedCentral

16.

Day, C. P., McComb, J. M., & Campbell, R. W. F. (1990). QT dispersion: An indication of arrhythmia risk in patients with long QT intervals. British Heart Journal, 63, 342–344.CrossRef

17.

Eroglu, M., Uz, O., Isilak, Z., Yalcin, M., Yildirim, A. O., & Kardesoglu, E. (2014). Carbon monoxide poisoning increases Tpeak-Tend dispersion and QTc dispersion. Cardiovascular Journal of Africa, 25(3), 106–109.CrossRef

18.

Prabhakaran, R., Marannan, N., Kumar, P., & Vrinda, V. (2017). A study on glasgow coma scale score and QTC interval in predicting prognosis and outcome of organophosphate and carbamate poisoning. International Archives of Integrated Medicine, 4(6), 1–7.

19.

Erre, G. L., Piras, A., Piga, M., Fedele, A. L., Mangoni, A. A., Lazzerini, P. E., et al. (2020). QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: Results from a multicentre cross-sectional study. Clinical and Experimental Rheumatology, 38(3), 516–522.PubMed

20.

Diane, L., & Jillian, L. (2004). Vital signs measurements. In J. Roberts, J. Hedges, & A. Chanmugam (Eds.), Clinical Procedures in Emergency Medicine (pp. 1–22). Reijka: InTechOpen.

21.

Flomenbaum, N., Goldfrank, L., Hoffman, R., Howland, M., Lewin, N., & Nelson, L. (2006). Initial evaluation of the patient: vital signs and toxic syndromes. In R. Hoffman, L. Nelson, M. Howland, N. Flomenbaum, & L. Goldfrank (Eds.), Goldfrank’s Toxicologic Emergencies (pp. 37–41). New York: The McGraw-Hill.

22.

Shurman, J., & Backer, R. C. (2006). Focus on urine drug monitoring. Practical Pain Management, 6, 60–67.

23.

Persson, H. E., Sjöberg, G. K., Haines, J. A., & De Garbino, J. P. (1998). Poisoning severity score Grading of acute poisoning. Journal of Toxicology: Clinical Toxicology. https://doi.org/10.3109/15563659809028940.CrossRef

24.

Bazett, H. C. (1920). An analysis of the time-relations of electrocardiograms. Heart, 7, 353–370.

25.

Moss, A. J. (1993). Measurement of the QT interval and the risk associated with QTc interval prolongation: A review. The American Journal of Cardiology. https://doi.org/10.1016/0002-9149(93)90036-C.CrossRefPubMed

26.

Atescelik, M., Bozdemir, M. N., Yildiz, M., Gurbuz, S., Ayranci, M., et al. (2012). QT dispersion in carbon monoxide poisoning. European Review for Medical and Pharmacological Sciences, 16(SUPPL. 1), 25–29.PubMed

27.

Manini, A. F., Nair, A. P., Vedanthan, R., Vlahov, D., & Hoffman, R. S. (2017). Validation of the prognostic utility of the electrocardiogram for acute drug overdose. Journal of the American Heart Association. https://doi.org/10.1161/JAHA.116.004320.CrossRefPubMedPubMedCentral

28.

Lee, H. L., Lin, H. J., Yeh, S. T. Y., Chi, C. H., & Guo, H. R. (2008). Presentations of patients of poisoning and predictors of poisoning-related fatality: Findings from a hospital-based prospective study. BMC Public Health. https://doi.org/10.1186/1471-2458-8-7.CrossRefPubMedPubMedCentral

29.

Manini, A. F., Nelson, L. S., Skolnick, A. H., Slater, W., & Hoffman, R. S. (2010). Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning. Journal of Medical Toxicology. https://doi.org/10.1007/s13181-010-0074-x.CrossRefPubMedPubMedCentral

30.

Elagamy, S. E., & Gabr, H. M. (2019). Predictors of the need for Intensive Care Unit admission in acute organophosphorus poisoning: One year prospective study. The Egyptian Journal of Forensic Sciences and Applied Toxicology. https://doi.org/10.21608/ejfsat.2019.11316.1065.CrossRef

31.

Mehrpour, O., Asadi, S., Yaghoubi, M. A., Azdaki, N., Mahmoodabadi, N., & Javadmoosavi, S. Y. (2019). Cardiogenic shock due to aluminum phosphide poisoning treated with intra-aortic balloon pump: A report of two cases. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-019-09513-0.CrossRefPubMed

32.

Mohamed, S., Hasb Elnabi, M., Moussa, M., Tawfik, H., & Adly, M. (2019). The accuracy comparison of scoring systems in the outcome prediction of acute organophosphate poisoning. Ain Shams Journal of Forensic Medicine and Clinical Toxicology. https://doi.org/10.21608/ajfm.2019.30444.CrossRef

33.

Abd Elghany, S., Heshmat, M., Oreby, M., & Elsarnagawy, G. (2018). Evaluation of various scoring systems in prediction of acute aluminum phosphide (ALP) poisoning outcome. Ain Shams Journal of Forensic Medicine and Clinical Toxicology. https://doi.org/10.21608/ajfm.2018.18202.CrossRef

34.

Darbar, D., Luck, J., Davidson, N., Pringle, T., Main, G., McNeill, G., et al. (1996). Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. British Medical Journal. https://doi.org/10.1136/bmj.312.7035.874.CrossRefPubMed

35.

Calder, K. K., Tomongin, C., Mallon, W. K., Genna, T., Bretsky, P., & Henderson, S. O. (2002). Manual Measurement of QT dispersion in patients with acute myocardial infarction and nondiagnostic electrocardiograms. Academic Emergency Medicine. https://doi.org/10.1111/j.1553-2712.2002.tb02177.x.CrossRefPubMed

36.

Magrì, D., Santolamazza, C., Limite, L., Mastromarino, V., Casenghi, M., Orlando, P., et al. (2017). QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal. Journal of Cardiology. https://doi.org/10.1016/j.jjcc.2017.01.006.CrossRefPubMed

37.

Gurkan, Y., Canatay, H., Toprak, A., Ural, E., & Toker, K. (2002). Carbon monoxide poisoning: A cause of increased QT dispersion. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1034/j.1399-6576.2002.460210.x.CrossRefPubMed

38.

Hanci, V., Ayoǧlu, H., Yurtlu, S., Yildirim, N., Okyay, D., Erdoǧan, G., et al. (2011). Effects of acute carbon monoxide poisoning on the P-wave and QT interval dispersions. Anadolu Kardiyoloji Dergisi. https://doi.org/10.5152/akd.2011.009.CrossRefPubMed

39.

Hassanian-Moghaddam, H., Amiri, H., Zamani, N., Rahimi, M., Shadnia, S., & Taherkhani, M. (2014). QT dispersion and prognostication of the outcome in acute cardiotoxicities: A comparison with SAPS II and APACHE II scoring systems. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-013-9236-9.CrossRefPubMed

40.

Eshraghi, A., Rajaei, N., Balali Mood, M., Vakili, V., & Ramezani, J. (2019). Changes of QT dispersion in patients suffering from aluminium phosphide poisoning (rice pill). Open Access Macedonian Journal of Medical Sciences, 7(14), 2251–2255.CrossRef

41.

Haugaa, K. H., Bos, J. M., Tarrell, R. F., Morlan, B. W., Caraballo, P. J., & Ackerman, M. J. (2013). Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clinic Proceedings. https://doi.org/10.1016/j.mayocp.2013.01.013.CrossRefPubMed

42.

Pickham, D., Helfenbein, E., Shinn, J. A., Chan, G., Funk, M., Weinacker, A., et al. (2012). High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) Study. Critical Care Medicine. https://doi.org/10.1097/CCM.0b013e318232db4a.CrossRefPubMed

43.

George, T. K., Chase, D., Peter, J. V., Satyendra, S., Kavitha, R., George, L. R., et al. (2015). Association between a prolonged corrected QT interval and outcomes in patients in a medical Intensive Care Unit. Indian Journal of Critical Care Medicine, 19(6), 326–332.CrossRef

44.

Kozik, T. M., & Wung, S. F. (2012). Acquired long QT syndrome: Frequency, onset, and risk factors in intensive care patients. Critical Care Nurse. https://doi.org/10.4037/ccn2012900.CrossRefPubMed

45.

Li, M., & Ramos, L. G. (2017). Drug-induced QT prolongation and torsades de Pointes. P & T: A Peer-Reviewed Journal for Formulary Management, 42(7), 473–477.

46.

Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., et al. (1991). The long QT syndrome Prospective longitudinal study of 328 families. Circulation, 1, 4. https://doi.org/10.1161/01.CIR.84.3.1136.CrossRef

47.

Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., et al. (1998). Influence of the genotype on the clinical course of the long-QT syndrome. New England Journal of Medicine. https://doi.org/10.1056/NEJM199810013391404.CrossRef

48.

Aziz, U., & Husain, A. (2015). Frequency of cardiac arrhythmias in patients with aluminum phosphide poisoning. Asia Pacific Journal of Medical Toxicology, 4(4), 147–150.

49.

Ahmadi, J., Joukar, S., Anani, H., & Karami-Mohajeri, S. (2018). Dihydroxyacetone as a definitive treatment for aluminium phosphide poisoning in rats. Arhiv za Higijenu Rada i Toksikologiju. https://doi.org/10.2478/aiht-2018-69-3106.CrossRefPubMed

50.

El-Ebiary, A., Elgazzar, F., Soliman, M., & Shouip, O. (2015). Predictors of prognosis in acute aluminum phosphide poisoning. Mansoura Journal of Forensic Medicine and Clinical Toxicology, 23(2), 13–27.CrossRef

51.

El-Sheikh, A., Hashem, A., Elgohary, M., Elfadl, A., & Lashin, H. (2017). Evaluation of the potential cardiotoxic effects in acute organophosphate toxicity as a prognostic factor. Tanta Medical Journal, 45(3), 115–121.CrossRef

52.

Chandrasekhar, V., Susmitha, K., Sarangapani, M., & Divya, A. (2020). A review on electrocardiographic findings in organophosphorus pesticide poisoning patients. Our Heritage, 68(30), 5094–5108.

53.

Hodeib, A., & Khalifa, H. (2020). Corrected QT interval as a predictor of outcomes in acute organophosphate poisoning cases. Ain Shams Journal of Forensic Medicine and Clinical Toxicology, 34(1), 34–40.CrossRef

54.

Shadnia, S., Okazi, A., Akhlaghi, N., Sasanian, G., & Abdollahi, M. (2009). Prognostic value of long QT interval in acute and severe organophosphate poisoning. Journal of Medical Toxicology. https://doi.org/10.1007/BF03178266.CrossRefPubMedPubMedCentral

55.

Mangshetty, B. G., Saraf, N., & Sharma, N. (2014). Study of clinical profile of organophosphate poisoning with special reference to electrocardiographic changes and electrolyte derangements. Journal of Evolution of Medical and Dental Sciences, 3(67), 14514–14523.CrossRef

56.

Farzaneh, E., Ghobadi, H., Akbarifard, M., Nakhaee, S., Amirabadizadeh, A., Akhavanakbari, G., et al. (2018). Prognostic factors in acute aluminium phosphide poisoning: A risk-prediction nomogram approach. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.13005.CrossRef

57.

Gündüz, E., Dursun, R., Icer, M., Zengin, Y., Güllü, M. N., Durgun, H. M., et al. (2015). Factors affecting mortality in patients with organophosphate poisoning. JPMA: The Journal of the Pakistan Medical Association, 65(9), 967–972.

58.

Liu, J. H., Chou, C. Y., Liu, Y. L., Liao, P. Y., Lin, P. W., Lin, H. H., et al. (2008). Acid-base interpretation can be the predictor of outcome among patients with acute organophosphate poisoning before hospitalization. American Journal of Emergency Medicine. https://doi.org/10.1016/j.ajem.2007.03.017.CrossRef

59.

Hosseini, S. F., Forouzesh, M., Maleknia, M., Valiyari, S., Maniati, M., & Samimi, A. (2020). The molecular mechanism of aluminum phosphide poisoning in cardiovascular disease: Pathophysiology and diagnostic approach. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-020-09592-4.CrossRefPubMed

60.

Subikshavarthni, S., & Selvan, R. (2019). Arterial blood gas as a prognostic tool in organophosphorus poisoning patients: A prospective observational study. International Journal of Scientific Study, 7, 82–87.

61.

Kraut, J. A., & Madias, N. E. (2010). Metabolic acidosis: Pathophysiology, diagnosis and management. Nat Rev Nephrol. https://doi.org/10.1038/nrneph.2010.33.CrossRefPubMed

62.

Orchard, C. H., & Kentish, J. C. (1990). Effects of changes of pH on the contractile function of cardiac muscle. American Journal of Physiology. https://doi.org/10.1152/ajpcell.1990.258.6.c967.CrossRef

63.

Orchard, C. H., & Cingolani, H. E. (1994). Acidosis and arrhythmias in cardiac muscle. Cardiovascular Research. https://doi.org/10.1093/cvr/28.9.1312.CrossRefPubMed

64.

Bai, J., Yin, R., Wang, K., & Zhang, H. (2017). Mechanisms underlying the emergence of post-acidosis arrhythmia at the tissue level: A theoretical study. Frontiers in Physiology. https://doi.org/10.3389/fphys.2017.00195.CrossRefPubMedPubMedCentral

65.

Kelleni, M., & Abdelbasset, M. (2018). Drug induced cardiotoxicity: Mechanism, Prevention and Management. Cardiotoxicity. https://doi.org/10.5772/intechopen.79611.CrossRef

Titel: Validation of Corrected and Dispersed QT as Predictors of Adverse Outcomes in Acute Cardiotoxicities
verfasst von: Ghada N. El-Sarnagawy
Aliaa E. Shaban
Heba I. Lashin
Publikationsdatum: 05.01.2021
Verlag: Springer US
Erschienen in: Cardiovascular Toxicology / Ausgabe 1/2022
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI: https://doi.org/10.1007/s12012-020-09629-8

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Diet-Derived Advanced Glycation End Products (dAGEs) Induce Proinflammatory Cytokine Expression in Cardiac and Renal Tissues of Experimental Mice: Protective Effect of Curcumin

Oxidative Stress Indices Changes in the Hearts of Rat Pups in Response to Maternal Buprenorphine Treatment during Gestation and Lactation

Refractory Shock from Amlodipine Overdose Overcomed with Hyperinsulinemia

In Vivo and In Vitro Cardioprotective Effect of Gossypin Against Isoproterenol-Induced Myocardial Infarction Injury

Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity

AAV9-Mediated Cardiac CNTF Overexpression Exacerbated Adverse Cardiac Remodeling in Streptozotocin-Induced Type 1 Diabetic Models